Logo-apb
Adv Pharm Bull. 2019;9(4): 632-639. doi: 10.15171/apb.2019.073
PMID: 31857968        PMCID: PMC6912185

Research Article

Evaluation of Immunogenic Effect of Toxoplasma gondii Recombinant SAG-1 Antigen with Propranolol as Adjuvant in BALB/c Mice

Esmaeil Abasi 1 ORCID, Shahram Shahabi 2 ORCID, Majid Golkar 3 ORCID, Peyman Khezri 1 ORCID, Habib Mohammadzadeh Hajipirloo 1 * ORCID

Cited by CrossRef: 3


1- Sánchez-López E, Corigliano M, Oliferuk S, Ramos-Duarte V, Rivera M, Mendoza-Morales L, Angel S, Sander V, Clemente M. Oral Immunization With a Plant HSP90-SAG1 Fusion Protein Produced in Tobacco Elicits Strong Immune Responses and Reduces Cyst Number and Clinical Signs of Toxoplasmosis in Mice. Front Plant Sci. 2021;12 [Crossref]
2- Wang S, Wang J, Fan Y, Zhang H, Wu J, Ying T, Ma H, Wang Q, Wang L, Wang Y, Tian X, Mei X, Zhang Z, Yang Z. Recombinant TgDDX3X DEAD-box protein confers partial protection in murine models of acute and chronic toxoplasmosis. Acta Tropica. 2025;270:107780 [Crossref]
3- Khorshidvand Z, Khosravi A, Mahboobian M, Larki-Harchegani A, Fallah M, Maghsood A. Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model. International Journal of Biological Macromolecules. 2022;208:962 [Crossref]
4- Mohammadi A, Abtahi Froushani S, DelireZh N, Ownagh A. Alum and metoclopramide synergistically enhance cellular and humoral immunity after immunization with heat-killed Salmonella typhimurium vaccine. International Immunopharmacology. 2021;101:108185 [Crossref]
5- Luo Y, He M, Yang S, Qian J, He Z, Xu J, Guo L, Xiao S, Fang R. Toxoplasma gondiiC2 Domain Protein Deletion Mutant as a Promising Vaccine Against Toxoplasmosis in Mice. Microbial Biotechnology. 2025;18(5) [Crossref]